Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trialH Bonnefoi, S Litière, M Piccart, et al.Breast Cancer Research and Treatment|November 28, 2017
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIESM C U Cheang, J M Bliss, G Viale, et al.British Journal of Cancer|August 2, 2012
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancerG Minuti, F Cappuzzo, R Duchnowska, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerT Brodowicz, T Ciuleanu, J Crawford, et al.The British Journal of Surgery|July 19, 2019
International multidisciplinary expert panel consensus on breast reconstruction and radiotherapyM B Nava, J R Benson, W Audretsch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ Y Douillard, S Siena, J Cassidy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†V Speirs, G Viale, K Mousa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2009
Third consensus on medical treatment of metastatic breast cancerS Beslija, J Bonneterre, H J Burstein, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2006
Second consensus on medical treatment of metastatic breast cancerS Beslija, J Bonneterre, H Burstein, et al.Journal of Cancer Policy|November 14, 2022
Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflictM Van Hemelrijck, L Fox, K Beyer, et al.Pageof 10